
Trump Nominates Scott Gottlieb to Lead FDA
The White House said President Trump will nominate Scott Gottlieb to the position of FDA commissioner.
On March 10, 2017 President Donald J. Trump nominated Scott Gottlieb, MD, to the position of FDA commissioner. A
“It’s critical to have the right person in charge of the FDA, an agency that affects virtually every American and regulates about a quarter of all consumer spending in the United States. Dr. Gottlieb has impressive qualifications helping American patients as both a physician and in his previous roles at the FDA,” Senator Lamar Alexander, chairman of the Senate Health Committee said in a
Gottlieb currently serves as a physician, a resident fellow at the American Enterprise Institute (AEI), and a venture partner at New Enterprise Associates. This is not Gottlieb’s first time working for the agency. In the past, he has taken on the roles of senior adviser for medical technology, director of medical policy development, and deputy commissioner for medical and scientific affairs, all at FDA, an AEI
Gottlieb also previously served as an advisor or board member at several Big Pharma companies including GlaxoSmithKline and Vertex Pharmaceuticals, a New York Times
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.